About Us

A New Hope for Brain Tumor Patients

The Ivy Brain Tumor Center at the Barrow Neurological Institute is a nonprofit translational science initiative established by a $50 million investment from the Ben & Catherine Ivy Foundation in partnership with the Barrow Neurological Foundation. This represents the largest single research  grant in the history of brain tumor research, worldwide. Our research program is singularly focused on discovering new therapies for brain tumor patients through a broad portfolio of pharmacodynamic- and pharmacokinetic-driven clinical trials, combining industry-partnered drug development with the nation’s largest operative brain tumor volume.

Our multidisciplinary team of brain tumor specialists and scientists are accelerating drug discovery and precision medicine in neuro-oncology in an effort to identify the most promising first-in-class therapies for brain tumor patients. The Ivy Brain Tumor Center’s central strategy is to introduce patients to these novel treatment paradigms, identify combined-agent strategies that sidestep brain tumor resistance mechanisms, and validate the utility of promising new regimens using randomized controlled clinical trials. Taken together, our innovative efforts in clinical trial design, expansive roster of new experimental agents, and access to the nation’s largest brain tumor patient population positions the Ivy Brain Tumor Center to redefine drug development for patients with brain tumors.

Two professionals reviewing paperwork

Our Vision

The Ivy Brain Tumor Center was founded to provide new avenues of hope for patients and families struggling with aggressive brain tumors. Our philosophy is to deploy scientifically rigorous and technologically advanced clinical trials that rapidly evaluate new therapeutic regimens and are tailored to exploit and attack individual tumor biologies.

Patient in bed next to her doctor standing close by

Our Mission

It is our mission is to increase life expectancy and contribute to a cure for malignant brain tumors by pioneering the largest, most advanced Phase 0 clinical trials program in the world. To achieve this goal, we invite patients and providers to submit a trials screening request and consider entry into our early-phase clinical trial program.

Healthcare professional working on a lab project

NeuroTrials, LLC

The Ivy Brain Tumor Center corporate structure resides within the independent, non-profit NeuroTrials, LLC. NeuroTrials can function as an autonomous Contract Research Organization and is the custodian of all research funds. It is responsible for all scientific and clinical contracting, trials infrastructure, accounting, and project management. This unique organization enables unprecedented operational efficiency, fiscal transparency, and unbiased programmatic decision-making.

Board of Directors

Katie CobbRead Bio

Katie Cobb

Thomas GornyRead Bio

Tomas Gorny

William PostRead Bio

William Post

David RauchRead Bio

David Rauch

Nader Sanai, MDRead Bio

Nader Sanai, MDChief Scientific Officer/Director

Ray ThurstonRead Bio

Ray Thurston

Scientific Advisory Board

Eric HollandRead Bio

Eric Holland

Frank McCormickRead Bio

Frank McCormick

Patricia LorussoRead Bio

Patricia LoRusso

Susan ChangRead Bio

Susan Chang

Doctor and patient meeting and shaking hands

Industry Collaborations

Industry Collaboration
Gloved hands lifting up a tab

What is a Phase 0 Clinical Trial?

Learn More